BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36952123)

  • 1. RTKN2 Inhibits the Growth, Migration, Invasion and Glycolysis of Lung Adenocarcinoma Cells by Inactivating the NF-κB Signalling Pathway.
    Wang N; Wang J
    Biochem Genet; 2023 Oct; 61(5):2135-2148. PubMed ID: 36952123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FAM83B promotes the invasion of primary lung adenocarcinoma via PI3K/AKT/NF-κB pathway.
    Zhang J; Wang J; Yue K; Li P; Shen W; Qiao X; Wang Y; Wu X
    BMC Pulm Med; 2023 Jan; 23(1):32. PubMed ID: 36690987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the functional role of SETD6 in lung adenocarcinoma.
    Xu J; Zhou H; Luo Z; Chen J; Liu M
    BMC Cancer; 2023 Jan; 23(1):18. PubMed ID: 36604642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXA1/UBE2T Inhibits CD8
    Pu J; Zhang D; Wang B; Zhu P; Yang W; Wang K; Yang Z; Song Q
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):134. PubMed ID: 38682180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-1-3p affects lung adenocarcinoma progression through E2F8 and regulating NF-кB pathway.
    Lin Q
    Cytokine; 2022 Aug; 156():155922. PubMed ID: 35660716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NPAS2, transcriptionally activated by ARRB1, promotes the malignant behaviours of lung adenocarcinoma cells and regulates the reprogramming of glucose metabolism.
    Wang S; Huang C; Zheng Y; Wu X; Zhong Y
    Clin Exp Pharmacol Physiol; 2024 May; 51(5):e13860. PubMed ID: 38584327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GIMAP7 inhibits epithelial-mesenchymal transition and glycolysis in lung adenocarcinoma cells via regulating the Smo/AMPK signaling pathway.
    Cui L; Shen Y; Duan S; Ding Q; Wang Y; Yang W; Chen Y
    Thorac Cancer; 2024 Feb; 15(4):286-298. PubMed ID: 38151913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC02535/miR-30a-5p/GALNT3 axis contributes to lung adenocarcinoma progression via the NF- κ B signaling pathway.
    Li Y; Zhao J; Zhang W; Wang A; Jiao M; Cai X; Zhu J; Liu Z; Huang JA
    Cell Cycle; 2022 Dec; 21(23):2455-2470. PubMed ID: 35852407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
    Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
    Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma.
    Wu Q; Li R; Wang QX; Zhang MY; Liu TT; Qu YQ
    J Transl Med; 2022 Jun; 20(1):260. PubMed ID: 35672776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-181 Functions as an Antioncogene and Mediates NF-κB Pathway by Targeting RTKN2 in Ovarian Cancers.
    Lin Z; Li D; Cheng W; Wu J; Wang K; Hu Y
    Reprod Sci; 2019 Aug; 26(8):1071-1081. PubMed ID: 30309296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RTKN2 knockdown alleviates the malignancy of breast cancer cells by regulating the Wnt/β-catenin pathway.
    Zhang X; Wang J; Li H
    Sci Rep; 2023 Dec; 13(1):23023. PubMed ID: 38155217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
    Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
    Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STRIP2, a member of the striatin-interacting phosphatase and kinase complex, is implicated in lung adenocarcinoma cell growth and migration.
    Qiu LM; Sun YH; Chen TT; Chen JJ; Ma HT
    FEBS Open Bio; 2020 Mar; 10(3):351-361. PubMed ID: 31901223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-96-5p Facilitates Lung Adenocarcinoma Cell Phenotypes by Inhibiting FHL1.
    Zhou F; Qian C; Chen T; Zang X
    Comput Math Methods Med; 2022; 2022():7891222. PubMed ID: 36017148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of CD147 inhibits cell proliferation, migration, invasion, lipid metabolism dysregulation and promotes apoptosis in lung adenocarcinoma via blocking the Rap1 signaling pathway.
    Zhang N; Liu Z; Lai X; Liu S; Wang Y
    Respir Res; 2023 Oct; 24(1):253. PubMed ID: 37880644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2.
    Wang G; Zhou Y; Chen W; Yang Y; Ye J; Ou H; Wu H
    Cancer Biomark; 2020; 28(4):549-559. PubMed ID: 32623387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MPZL1 Promotes Lung Adenocarcinoma Progression by Enhancing Tumor Proliferation, Invasion, Migration, and Suppressing Immune Function via Transforming Growth Factor-β1.
    Wang A; Fan F; Zang C; Li C; Hong H; Wang Z; Gao Y; Chen L; Yu X; Zhou C; Zhao C
    Hum Gene Ther; 2023 Jun; 34(11-12):540-553. PubMed ID: 37183407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GRIN2D knockdown suppresses the progression of lung adenocarcinoma by regulating the E2F signalling pathway.
    Chen Z; Song Y; Li P; Gao W
    Cell Signal; 2023 Jul; 107():110685. PubMed ID: 37084840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
    Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X
    Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.